» Articles » PMID: 22044905

High Throughput Virus Plaque Quantitation Using a Flatbed Scanner

Overview
Journal J Virol Methods
Specialty Microbiology
Date 2011 Nov 3
PMID 22044905
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The plaque assay is a standard technique for measuring influenza virus infectivity and inhibition of virus replication. Counting plaque numbers and quantifying virus infection of cells in multiwell plates quickly, accurately and automatically remain a challenge. Visual inspection relies upon experience, is subjective, often time consuming, and has less reproducibility than automated methods. In this paper, a simple, high throughput imaging-based alternative is proposed which uses a flatbed scanner and image processing software to quantify the infected cell population and plaque formation. Quantitation results were evaluated with reference to visual counting and achieved better than 80% agreement. The method was shown to be particularly advantageous in titration of the number of plaques and infected cells when influenza viruses produce a heterogeneous population of small plaques. It was also shown to be insensitive to the densities of plaques in determination of neutralization titres and IC(50)s of drug susceptibility. In comparison to other available techniques, this approach is cost-effective, relatively accurate, and readily available.

Citing Articles

mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020.

Allen J, Ross T Front Immunol. 2024; 15:1334670.

PMID: 38533508 PMC: 10963417. DOI: 10.3389/fimmu.2024.1334670.


Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development.

Wang Y, Troutman M, Hofmann C, Gonzalez A, Song L, Levin R Front Immunol. 2024; 15:1356600.

PMID: 38410513 PMC: 10895029. DOI: 10.3389/fimmu.2024.1356600.


Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.

Huang Y, Shi H, Forgacs D, Ross T Vaccine. 2024; 42(5):1184-1192.

PMID: 38296701 PMC: 11157428. DOI: 10.1016/j.vaccine.2023.12.084.


Machine-learning-based automated quantification machine for virus plaque assay counting.

Phanomchoeng G, Kukiattikoon C, Plengkham S, Boonyasuppayakorn S, Salakij S, Poomrittigul S PeerJ Comput Sci. 2022; 8:e878.

PMID: 35494866 PMC: 9044226. DOI: 10.7717/peerj-cs.878.


Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.

Allen J, Ross T J Virol. 2022; 96(7):e0165221.

PMID: 35289635 PMC: 9006891. DOI: 10.1128/jvi.01652-21.